Lowest Price Guaranteed From USD 5,499
Published
June 2021
Pages
132
View Count
4622
The “Polycystic Ovarian Syndrome (PCOS): Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment of polycystic ovarian syndrome.
This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the product’s drug class, route of administration, type of treatment, regulatory milestones, and other development activities.
One of the key objectives of the report was to estimate the existing market size and the future opportunity of therapies for polycystic ovarian syndrome, over the next decade. Based on multiple parameters, such as disease prevalence, anticipated adoption of the forecasted therapies and the likely selling price of such therapeutic products, we have provided informed estimates on the evolution of the market for the period 2021-2031.
1. Preface
2. Executive Summary
3. Introduction
4. Pipeline Review
4.1. Chapter Overview
4.2. Polycystic Ovarian Syndrome: Development Pipeline
4.3. Polycystic Ovarian Syndrome: Pipeline Analysis
4.3.1. Analysis by Phase of Development
4.3.2. Analysis by Drug Class
4.3.3. Analysis by Symptoms Treated
4.3.4. Analysis by Drug Class and Symptoms Treated
4.3.5. Analysis by Line of Treatment
4.3.6. Analysis by Route of Administration
4.4. Polycystic Ovarian Syndrome: Developers
4.4.1. Analysis by Year of Establishment
4.4.2. Analysis by Company Size
4.4.3. Analysis by Geographical Location
4.4.4. Analysis by Type of Player
4.4.5. Analysis by Most Active Players
4.4.6. Analysis by Drug Class
5. Company Profiles
6. KOL Analysis
7. Grants Analysis
8. Clinical Trials Analysis
9. Patent Analysis
10. Market Sizing and Opportunity Analysis
11. Appendix 1: Tabulated Data
12. Appendix 2: List of Companies and Organizations